查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2014855

靜脈輸液袋市場：2026-2032年全球市場預測（依產品類型、材料、包裝形式、流速、最終用戶和應用分類）

IV Bags Market by Product Type, Material, Packaging Type, Flow Rate, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈輸液袋市場價值將達到 288.1 億美元，到 2026 年將成長至 308.2 億美元，到 2032 年將達到 472.7 億美元，複合年成長率為 7.32%。

主要市場統計數據
基準年 2025 288.1億美元
預計年份：2026年 308.2億美元
預測年份：2032年 472.7億美元
複合年成長率 (%) 7.32%

對多方面的靜脈輸液 (IV) 環境進行簡要概述，重點關注臨床應用案例、材料演變以及影響供應商和提供者選擇的結構化細分市場。

靜脈輸液系統仍然是急性和慢性照護的重要組成部分，在各種臨床環境中支援靜脈輸液治療、藥物輸注、營養支持和緊急復甦。近年來，多種因素共同作用，使得靜脈輸液袋設計和供應的韌性變得愈發重要。具體而言，這些因素包括材料科學領域從傳統塑化劑轉向新型材料、對病人安全和藥物相容性的日益重視，以及服務範圍從醫療機構擴展到居家醫療和門診環境。這些因素共同迫使製造商和供應商重新評估其產品系列、採購流程和臨床工作流程。

找出材料、監管和醫療保健服務變革的交集，以重組靜脈輸液袋設計、製造重點和臨床部署策略。

輸液袋市場正經歷著變革性的轉變，這主要得益於材料創新、法規的不斷改進以及醫療服務模式的轉變，這些因素共同重塑了產品規格和採購邏輯。聚合物科學的進步正在加速採用替代傳統PVC配方的材料，這主要是由於人們對塑化劑過渡、藥物相容性和環境永續性的擔憂。因此，製造商正在投資開發醋酸乙烯酯（EVA）和聚烯的加工能力，以滿足臨床醫生對更安全、化學惰性容器的需求。

分析 2025 年關稅措施帶來的累積營運和商業影響，以及這些影響對供應商策略、庫存設計和採購選擇的影響。

2025年關稅及相關貿易措施的實施，靜脈注射的採購成本、供應商選擇和庫存策略產生了累積影響。關稅帶來的成本壓力促使下游買家重新評估其採購區域，供應商多元化和近岸外包對於降低貿易政策波動風險日益重要。採購團隊在重組供應商層級時，越來越注重平衡接收成本與供應商的可靠性、監管核准和品質認證。

詳細的細分分析揭示了應用、材料選擇、包裝結構、流動特性、最終用戶環境和產品類型如何造成臨床需求和商業性需求之間的差異。

細分市場洞察揭示了臨床環境、材料、包裝類型、流速、終端用戶類型和產品類型等方面的微妙趨勢，每種趨勢都具有其獨特的戰略意義。按應用領域分類，門診和居家醫療與醫院環境的需求模式有所不同；即使在醫院內部，不同的使用情境（例如普通病房、重症監護室和手術室）也存在不同的需求。這些差異會影響容器的堅固度、符合性規範和標籤清晰度。材料選擇是關鍵的差異化因素。從聚氯乙烯 (PVC) 轉向非聚氯乙烯材料（例如乙烯-醋酸乙烯酯共聚物和聚烯）的促進因素是出於對藥物相互作用和環境因素的擔憂，這需要對生產過程和驗證方案進行相應的調整。

從區域比較的觀點解釋美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響生產選擇、監管反應和臨床引入模式。

區域趨勢影響供應側的生產能力和需求模式，每個宏觀區域都展現出其獨特的法規結構、製造生態系統和臨床應用曲線。在美洲，完善的臨床基礎設施和健全的採購管道促進了新材料和高利潤特種產品的快速引入。同時，製造商與大規模醫療保健系統之間的地理位置接近性，也有利於在合規性和產品測試方面密切合作。在歐洲、中東和非洲，監管的異質性和報銷機制的差異，既給供應商帶來了挑戰，也帶來了機遇，他們需要應對各國的醫療保健系統和本地認證流程，而區域中心在分銷和本地生產方面繼續發揮著至關重要的作用。

企業策略洞察：製造商​​和供應商如何透過材料創新、品質系統和夥伴關係模式來獲得臨床和商業優勢。

在公司層面，我們可以觀察到一系列通用的策略性因應措施。具體而言，這些措施包括投資材料創新、擴大無菌生產能力，以及尋求策略夥伴關係和契約製造協議以加速產能部署。主要企業正透過檢驗的非PVC產品線來解決藥物相容性和安全性問題，從而實現差異化競爭；而那些生命週期成本和性能仍然有利的企業則在最佳化PVC配方。同時，一些企業正在開發多腔室解決方案和專用給藥系統，以搶佔高價值的臨床市場，並滿足臨床醫生對簡化配藥流程和縮短製備時間的需求。

與製造商、供應商和採購經理共同使用的優先可操作建議摘要，旨在增強靜脈注射產品系列的韌性、創新和市場應對力。

產業領導者應採取一系列優先且切實可行的措施，使其營運能力與不斷變化的臨床需求和政策環境相適應。首先，應實現供應商多元化，並建立區域生產緩衝，以降低跨境政策風險，同時維持對本地需求的應對力。這將有助於減少關稅波動和物流不穩定造成的干擾。其次，應加快對乙烯-醋酸乙烯酯共聚物（EVA）和聚烯等非聚氯乙烯（PVC）材料的投資，同時在臨床適用的情況下保留檢驗的PVC產品，以確保產品系列符合廣泛的適用性和永續性標準。

為了支持我們確鑿的結論，我們需要對我們的研究方案進行透明的解釋，該方案結合了對臨床醫生和供應商的初步訪談以及包括技術審查、供應鏈映射和三角驗證在內的二次分析。

本研究整合了結構化訪談、技術白皮書、監管文件和公開資訊披露等證據，並將其與供應鏈圖譜和以材料為重點的實驗室評估結果進行交叉比對。主要研究包括與醫院病房、重症監護室團隊和門診的醫護人員，以及採購負責人、契約製造和聚合物供應商的訪談。二級資訊來源提供了監管趨勢、滅菌規程和醫療設備合規性文獻的背景檢驗，從而支持對其對產品和生產的影響進行深入分析。

將核心策略挑戰與物質轉型、醫療保健服務轉型和貿易趨勢連結起來，並將它們整合到一致的市場和產品決策藍圖中。

總之，輸液袋產業正處於策略轉折點，材料科學、供應鏈韌性和不斷變化的醫療保健格局在此交匯，迫使企業重新調整產品優先順序和商業策略。相關人員認知到，諸如轉向非PVC材料、多腔和特殊劑量形式的日益重要以及醫療服務向門診和居家醫療的分散化等趨勢並非孤立存在，而是相互關聯的促進因素，需要研發、生產和市場准入等各個環節協同應對。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：輸液袋市場：依產品類型分類

  • 特殊藥物管理
  • 標準滴注液
  • 全靜脈營養

第9章：輸液袋市場：依材料分類

  • 不含聚氯乙烯
    • 乙烯-醋酸乙烯酯
    • 聚烯
  • PVC

第10章：輸液袋市場：依包裝類型分類

  • 多重腔
    • 雙腔體
    • 三腔體
  • 單室

第11章 輸液袋市場：依流速分類

  • 宏觀滴注
  • 微滴

第12章：輸液袋市場：依最終用戶分類

  • 門診部
  • 診所
  • 居家照護中心
  • 醫院

第13章：輸液袋市場：依應用領域分類

  • 門診治療
  • 居家照護
  • 醫院
    • 普通病房
    • ICU
    • 手術室

第14章：輸液袋市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：輸液袋市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：輸液袋市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國靜脈輸液袋市場

第18章：中國輸液袋市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, SA
  • ICU Medical, Inc.
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Technoflex
  • Terumo Corporation
  • Vygon SA
Product Code: MRR-43470FC6083B

The IV Bags Market was valued at USD 28.81 billion in 2025 and is projected to grow to USD 30.82 billion in 2026, with a CAGR of 7.32%, reaching USD 47.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 28.81 billion
Estimated Year [2026] USD 30.82 billion
Forecast Year [2032] USD 47.27 billion
CAGR (%) 7.32%

A concise orientation to the multifaceted intravenous infusion environment highlighting clinical use cases, material evolutions, and the structured segments that define supplier and provider choices

Intravenous infusion systems remain a foundational component of acute and chronic care delivery, supporting fluid therapy, drug administration, nutrition, and emergency resuscitation in diverse clinical environments. Recent years have seen converging pressures that elevate the strategic importance of IV bag design and supply resilience: shifts in material science away from legacy plasticizers, heightened emphasis on patient safety and drug compatibility, and expanding delivery beyond institutional walls into homecare and ambulatory settings. Together, these forces require manufacturers and providers to reassess portfolio composition, procurement practices, and clinical workflows.

As stakeholders evaluate product choices, they must consider multiple dimensions of the market structure. Based on Application, market study accounts for Ambulatory Care, Homecare, and Hospital settings, with Hospital environments further delineated across General Ward, ICU, and Operating Theatre. Based on Material, focus spans Non-PVC and PVC formats, where Non-PVC options are further categorized into Ethylene Vinyl Acetate and Polyolefin. Based on Packaging Type, devices are examined across Multi-Chamber and Single Chamber configurations, with Multi-Chamber split into Dual Chamber and Triple Chamber options. Based on Flow Rate, clinical use differentiates Macrodrip and Microdrip systems. Based on End User, the landscape includes Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals. Based on Product Type, the market is analyzed across Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition. This multidimensional framing establishes a foundation for the deeper analytical themes explored in subsequent sections.

Identification of converging material, regulatory, and care-delivery transformations reshaping intravenous solution design, manufacturing prioritization, and clinical deployment strategies

The IV bags landscape is experiencing transformative shifts driven by material innovation, regulatory evolution, and shifts in care delivery models that collectively reconfigure product specification and procurement logic. Advances in polymer science are accelerating the adoption of alternatives to traditional PVC formulations, driven by concerns about plasticizer migration, drug compatibility, and environmental sustainability. Consequently, manufacturers are investing in Ethylene Vinyl Acetate and Polyolefin processing capabilities to meet clinician demands for safer, more chemically inert containers.

Concurrently, care delivery is decentralizing: ambulatory and homecare settings are playing an expanding role in therapies historically confined to hospitals, which places a premium on packaging formats that simplify administration and reduce risk in non-clinical environments. Multi-chamber systems that enable co-administration and extended stability are becoming more relevant for specialty drug delivery and total parenteral nutrition, while flow-rate tailored solutions such as macrodrip and microdrip devices are seeing differentiated clinical adoption. Moreover, digital traceability and single-use stewardship programs are altering lifecycle economics. Taken together, these trends create an imperative for suppliers to align R&D, manufacturing capacity, and regulatory strategies with shifting clinical and commercial parameters.

Analysis of the cumulative operational and commercial consequences stemming from tariff measures in 2025 and how they are influencing supplier strategy, inventory design, and procurement choices

The imposition of tariffs and related trade measures in 2025 has introduced a cumulative set of effects on procurement costs, supplier selection, and inventory strategies across the intravenous supply chain. Tariff-induced cost pressure has prompted downstream buyers to reassess sourcing geographies, with an emphasis on supplier diversification and nearshoring to buffer exposure to trade policy volatility. Procurement teams are increasingly balancing landed cost with supplier reliability, regulatory approvals, and quality certification when reconfiguring supplier tiers.

In practical terms, manufacturers and contract packagers have adjusted pricing models and renegotiated contracts with raw material suppliers to preserve margin while maintaining sterility and compliance standards. The heavier administrative burden for cross-border shipments has elevated the value of vertically integrated suppliers and regional manufacturing footprints capable of servicing local demand with reduced customs complexity. Inventory policies have shifted toward a hybrid approach that blends strategic safety stocks with just-in-time replenishment for high-turn items, supported by enhanced visibility tools. Overall, the tariff environment has accelerated structural adjustments that favor resilience, traceability, and flexible production capacity.

Detailed segmentation analysis uncovering how application, material choice, packaging architecture, flow characteristics, end-user contexts, and product types drive differentiated clinical and commercial requirements

Segmentation insights reveal nuanced trajectories across clinical settings, materials, packaging formats, flow configurations, end-user types, and product categories, each with distinct strategic implications. Application-wise, demand patterns differ between Ambulatory Care and Homecare versus Hospital environments, and hospitals themselves present differentiated needs across General Ward, ICU, and Operating Theatre use cases; this variation influences container robustness, compatibility specifications, and labeling clarity. Material selection is a critical differentiator: the move from PVC toward Non-PVC options such as Ethylene Vinyl Acetate and Polyolefin is motivated by drug interaction concerns and environmental considerations, and it necessitates corresponding changes in manufacturing processes and validation protocols.

Packaging type has emerged as a key point of product differentiation, with Single Chamber solutions remaining core for standard IV fluids while Multi-Chamber formats, including Dual Chamber and Triple Chamber designs, are gaining prominence in specialty drug delivery and therapies requiring admixture at the point of care. Flow rate segmentation between Macrodrip and Microdrip reflects clinical application specificity, with macrodrip favored for rapid fluid resuscitation and microdrip optimized for precise pediatric or ambulatory administration. End users span Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals, and each requires tailored training, labeling, and distribution approaches. Product-type distinctions among Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition further influence shelf-life requirements, compatibility testing, and cold-chain or controlled-environment packaging needs. These segmentation insights should guide product portfolio rationalization, investment in targeted manufacturing capabilities, and clinical market engagement.

Comparative regional perspectives explaining how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence manufacturing choices, regulatory navigation, and clinical adoption patterns

Regional dynamics are shaping both supply-side capacity and demand patterns, with each macro-region presenting distinct regulatory frameworks, manufacturing ecosystems, and clinical adoption curves. In the Americas, established clinical infrastructures and robust purchasing channels facilitate rapid adoption of new materials and higher-margin specialty products, while proximity between manufacturers and large healthcare systems supports close collaboration on compatibility testing and product trials. Across Europe, Middle East & Africa, regulatory heterogeneity and reimbursement variability create both challenges and opportunities for suppliers able to navigate national health systems and local certification pathways, and regional hubs continue to be important for distribution and localized manufacturing.

In the Asia-Pacific region, production scale and cost competitiveness remain central, supported by a growing number of polymer processors and contract manufacturers capable of supplying both domestic and export markets. The region also shows accelerating clinical adoption in ambulatory and homecare settings, which increases demand for packaging that is user-friendly and compatible with decentralized administration. Cross-region trade dynamics, including tariff considerations and logistics constraints, have encouraged a more localized approach to capacity planning, with many companies adopting regional manufacturing footprints to reduce lead times and regulatory friction. These geographic distinctions should inform market entry strategies, regulatory investment, and supply-chain design.

Insights into corporate strategies showing how manufacturers and suppliers are adopting material innovation, quality systems, and partnership models to capture clinical and commercial advantage

Company-level behavior reveals a set of common strategic responses: investments in material innovation, scaling of sterile manufacturing capacity, and pursuit of strategic partnerships or contract manufacturing agreements to accelerate capability deployment. Leading firms are differentiating through validated Non-PVC product lines that address drug compatibility and safety concerns, while others are optimizing PVC formulations where lifecycle cost and performance remain favorable. In parallel, a subset of companies is developing multi-chamber solutions and specialty delivery systems to capture higher-value clinical segments and to align with clinician needs for simplified admixture and reduced preparation time.

Operationally, firms are prioritizing regulatory harmonization, quality management systems, and digital traceability across manufacturing and distribution channels to meet buyer expectations for transparency and reliability. Several companies are also exploring sustainability initiatives, such as recyclable materials, reduced energy consumption in sterilization, and packaging minimization, as differentiators in procurement decisions. These strategic moves illustrate an industry balancing incremental product evolution with targeted innovation to address the combined pressures of clinical complexity, regulatory scrutiny, and supply-chain resiliency.

A concise set of prioritized, actionable recommendations for manufacturers, suppliers, and procurement leaders to enhance resilience, innovation, and market responsiveness in intravenous product portfolios

Industry leaders should adopt a set of prioritized, actionable steps that align operational capability with evolving clinical requirements and policy landscapes. First, diversify supplier bases and create regional manufacturing buffers to mitigate cross-border policy risk while preserving responsiveness to local demand; this will reduce disruption from tariff shifts and logistics volatility. Second, accelerate investment in Non-PVC materials such as Ethylene Vinyl Acetate and Polyolefin while maintaining validated PVC options where clinically appropriate, ensuring that product portfolios meet a spectrum of compatibility and sustainability criteria.

Third, prioritize multi-chamber and specialty delivery platforms for segments where admixture convenience and drug stability command clinical preference, and tailor packaging and labeling for ambulatory and homecare environments. Fourth, invest in digital traceability and inventory optimization tools to improve supply visibility and reduce waste, enabling hybrid inventory strategies that balance safety stocks with efficient turnover. Fifth, engage proactively with regulators and large purchasers to streamline approvals and align product specifications with procurement requirements. Finally, pursue targeted partnerships with clinical leaders to validate product performance in ICU, Operating Theatre, and home settings, thereby shortening adoption curves and strengthening value propositions.

A transparent explanation of research protocols combining primary clinician and supplier interviews with technical review, supply-chain mapping, and triangulated secondary analysis to support robust conclusions

This research synthesized evidence from structured primary interviews, technical white papers, regulatory filings, and public company disclosures, triangulated with supply-chain mapping and material-focused laboratory assessments. Primary research included conversations with clinicians across hospital wards, ICU teams, and ambulatory care practitioners, as well as procurement specialists, contract manufacturers, and polymer suppliers. Secondary sources provided contextual validation on regulatory trends, sterilization protocols, and device compatibility literature, supporting a robust analysis of product and manufacturing implications.

Analytical methods emphasized thematic coding of qualitative inputs, comparative assessment of material performance characteristics, and scenario-based evaluation of tariff and logistics disruptions. Limitations are acknowledged where proprietary manufacturing data or confidential commercial terms constrains full visibility; in these instances, findings were corroborated through multiple independent sources to ensure reliability. The methodology prioritizes a balanced view across clinical, regulatory, and supply-chain dimensions to furnish decision-relevant insights for commercial and clinical stakeholders.

Synthesis of core strategic imperatives that tie material transitions, care delivery shifts, and trade dynamics into a cohesive roadmap for market and product decisions

In conclusion, the IV bags sector is at a strategic inflection point where material science, supply-chain resilience, and evolving care settings converge to reshape product priorities and commercial strategies. Stakeholders must recognize that the shift toward Non-PVC materials, the growing relevance of multi-chamber and specialty delivery formats, and the decentralization of care into ambulatory and home settings are not isolated trends but interconnected drivers that together demand integrated responses across R&D, manufacturing, and market access functions.

Moreover, the tariff and trade environment has accelerated a rethinking of sourcing and inventory strategies, rewarding firms that combine regional capacity with validated quality systems and strong regulatory pathways. Companies that proactively align product portfolios with clinical workflows, invest in traceability and sustainability, and engage early with purchasers and regulators will be best positioned to convert these structural shifts into competitive advantage. The summary insights presented here offer a strategic roadmap for leaders preparing to navigate the next phase of evolution in intravenous therapy solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Bags Market, by Product Type

  • 8.1. Specialty Drug Delivery
  • 8.2. Standard IV Solutions
  • 8.3. Total Parenteral Nutrition

9. IV Bags Market, by Material

  • 9.1. Non-PVC
    • 9.1.1. Ethylene Vinyl Acetate
    • 9.1.2. Polyolefin
  • 9.2. PVC

10. IV Bags Market, by Packaging Type

  • 10.1. Multi-Chamber
    • 10.1.1. Dual Chamber
    • 10.1.2. Triple Chamber
  • 10.2. Single Chamber

11. IV Bags Market, by Flow Rate

  • 11.1. Macrodrip
  • 11.2. Microdrip

12. IV Bags Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Homecare Centers
  • 12.4. Hospitals

13. IV Bags Market, by Application

  • 13.1. Ambulatory Care
  • 13.2. Homecare
  • 13.3. Hospital
    • 13.3.1. General Ward
    • 13.3.2. ICU
    • 13.3.3. Operating Theatre

14. IV Bags Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. IV Bags Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. IV Bags Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States IV Bags Market

18. China IV Bags Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. B. Braun Melsungen AG
  • 19.6. Baxter International Inc.
  • 19.7. Fresenius Kabi AG
  • 19.8. Grifols, S.A.
  • 19.9. ICU Medical, Inc.
  • 19.10. Nipro Corporation
  • 19.11. Otsuka Pharmaceutical Co., Ltd.
  • 19.12. Pfizer Inc.
  • 19.13. Technoflex
  • 19.14. Terumo Corporation
  • 19.15. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IV BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IV BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 172. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. GCC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 176. GCC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GCC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 202. G7 IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 206. G7 IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. G7 IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. G7 IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 216. NATO IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NATO IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)